Literature DB >> 12683421

Cyclooxygenase-2 and the kidney: functional and pathophysiological implications.

Raymond C Harris1.   

Abstract

In adult mammalian kidney, cyclooxygenase-2 (COX-2) expression is found in restricted subpopulations of cells. High levels of expression can be detected in the macula densa (MD) and associated cortical thick ascending limb of Henle (cTALH) cells and medullary interstitial cells (MICs). In human biopsy specimens, COX-2 expression is also detected in glomerular podocytes and increased podocyte expression is seen in experimental models of progressive glomerular injury. Physiological regulation of COX-2 in these cellular compartments suggests functional roles for eicosanoid products of the enzyme. COX-2 expression increases in high-renin states (salt restriction, angiotensin-converting enzyme inhibition, renovascular hypertension) and selective COX-2 inhibitors significantly decrease plasma renin levels, renal renin activity and mRNA expression. There is evidence for negative regulation of MD/cTALH COX-2 by angiotensin II and by glucocorticoids and mineralocorticoids. Conversely, nitric oxide (NO) generated by neuronal nitric oxide synthase (nNOS) is a positive modulator of COX-2 expression. Decreased extracellular chloride increases COX-2 expression in cultured cTALH, an effect mediated by increased p38 MAP kinase activity and, in vivo, a sodium-deficient diet increases expression of activated p38 in MD/cTALH. In contrast to COX-2 in MD/cTALH, COX-2 expression in MICs increases in response to a high-salt diet, as well as water deprivation. Studies in cultured MICs confirm that expression is increased in response to hypertonicity, and expression is mediated at least in part by nuclear factor-kappaB (NFkappaB) activation. COX-2 inhibition leads to apoptosis of MICs in response to hypertonicity in vitro and following water deprivation in vivo. In addition, COX-2 metabolites appear to be important mediators of medullary blood flow and renal salt handling. Therefore, there is increasing evidence that COX-2 is an important physiological mediator of kidney function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12683421

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  7 in total

1.  Osmoadaptation of Mammalian cells - an orchestrated network of protective genes.

Authors:  Küper Christoph; Franz-X Beck; Wolfgang Neuhofer
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

2.  Oxylipin profiling of human plasma reflects the renal dysfunction in uremic patients.

Authors:  Da-Yong Hu; Ying Luo; Chang-Bin Li; Chun-Yu Zhou; Xin-Hua Li; Ai Peng; Jun-Yan Liu
Journal:  Metabolomics       Date:  2018-08-01       Impact factor: 4.290

Review 3.  New insights into sodium transport regulation in the distal nephron: Role of G-protein coupled receptors.

Authors:  Luciana Morla; Aurélie Edwards; Gilles Crambert
Journal:  World J Biol Chem       Date:  2016-02-26

4.  Sirt1 activation protects the mouse renal medulla from oxidative injury.

Authors:  Wenjuan He; Yingying Wang; Ming-Zhi Zhang; Li You; Linda S Davis; Hong Fan; Hai-Chun Yang; Agnes B Fogo; Roy Zent; Raymond C Harris; Matthew D Breyer; Chuan-Ming Hao
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

5.  ATP as a mediator of macula densa cell signalling.

Authors:  P Darwin Bell; Peter Komlosi; Zhi-Ren Zhang
Journal:  Purinergic Signal       Date:  2009-03-28       Impact factor: 3.765

6.  A comparison of the blood pressure changes of lumiracoxib with those of ibuprofen and naproxen.

Authors:  Michael E Farkouh; Freek W A Verheugt; Sean Ruland; Howard Kirshner; Raban Jeger; Xavier Gitton; Gerhard Krammer; Kirstin Stricker; Peter Sallstig; Bernhard Mellein; Patrice Matchaba; James H Chesebro
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738

7.  Generation of a tenascin-C-CreER2 knockin mouse line for conditional DNA recombination in renal medullary interstitial cells.

Authors:  Wenjuan He; Qionghong Xie; Yingying Wang; Jing Chen; Min Zhao; Linda S Davis; Matthew D Breyer; Guoqiang Gu; Chuan-Ming Hao
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.